Mainstream

Profound medical targets 70–75% revenue growth in 2025 as tulsa ai and captain trial progress fuel confidence

Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence

Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence

Post Contentprn:ca, profRead More

You might also be interested in reading More than three-quarters of central banks considering a CBDC: research.

August 15, 2025
In Mainstream